Coenzyme Q10 (CoQ10) is an endogenous lipid-soluble quinone with an important role in mitochondrial electron transport and antioxidant protection. Its biological relevance is particularly associated with the maintenance of cellular energy metabolism and protection against oxidative injury. This article presents a comparative, literature-based analytical framework for examining the potential relationship between dietary CoQ10 supplementation, haematological indices, and splenic tissue architecture. The analysis synthesizes the supplied literature concerning CoQ10 distribution, antioxidant function, absorption, bioavailability, mitochondrial dysfunction, and cellular oxidative processes. Particular attention is given to the theoretical mechanisms through which improved CoQ10 availability may influence erythrocyte stability, systemic oxidative balance, and the structural integrity of splenic tissue. The literature indicates that CoQ10 bioavailability is strongly influenced by formulation and absorption characteristics, while its antioxidant activity provides a plausible mechanistic foundation for cellular protection. The analysis further establishes that haematological responses and splenic morphology should be interpreted as interconnected indicators rather than isolated outcomes. However, the supplied references provide substantially stronger evidence concerning CoQ10 pharmacology, antioxidant activity, bioavailability, and mitochondrial function than direct evidence concerning CoQ10-induced changes in splenic histoarchitecture. Consequently, the article identifies an important research gap and proposes a structured comparative methodology for future experimental investigation. The resulting framework may support more rigorous assessment of dose, formulation, exposure, haematological response, and tissue-level outcomes associated with dietary CoQ10 supplementation.
A Comparative Analysis of Dietary Coenzyme Q10 Supplementation on Haematological Indices and Splenic Tissue Architecture
Keywords:
Abstract
References
Abdel-Hamid, Sameh and Betz G. “A Novel Tool for The Prediction of Tablet Sticking During High Speed Compaction.” Pharm Dev Technol 17 (2012): 747–754.
Aberg, Fredrik, Appelkvist EL, Dallner G and Ernster L, et al. “Distribution and Redox State of Ubiquinones In Rat and Human Tissues.” Arch Biochem Biophys 295 (1992): 230–234.
Adjei, Alex A. “A Review of The Pharmacology and Clinical Activity of New Chemotherapy Agents for The Treatment of Colorectal Cancer.” Br J Clin Pharmacol 48 (1999): 265–277.
Aherne GW, Hardcastle A, Raynaud F and Jackman AL, et al. “Immunoreactive dUMP and TTP Pools As An Index of Thymidylate Synthase Inhibition; Effect of Tomudex (ZD1694) and a Nonpolyglutamated Quinazoline Antifolate (CB30900) in L1210 Mouse Leukaemia Cells.” Biochem Pharmacol 51 (1996): 1293–1301.
Alam, Ashraful M, Rahman MM. “Mitochondrial Dysfunction In Obesity: Potential Benefit and Mechanism of Coenzyme Q10 Supplementation In Metabolic Syndrome.” J Diabetes Metab Disord 13 (2014): 60.
Alexieva, Bistra, Markova T, Nikolova E and Aragan Y, et al. “Free Radicals, Antioxidants and Cancer Chemotherapy.” Acta Med Kinki Univ 35 (2010): 57–65.
Balakrishnan, Prabagar, Lee BJ, Oh DH and Kim JO, et al. “Enhanced Oral Bioavailability of Coenzyme Q10 by Self-Emulsifying Drug Delivery Systems.” Int J Pharm 374 (2009): 66–72.
Barakat, Abdulwahab, Shegokar R, Dittgen M and Muller RH, et al. “Coenzyme Q10 Oral Bioavailability: Effect of Formulation Type.” J Pharm Investig 43 (2013): 431–451.
Beg, Sarwar, Javed S and JKohli K. “Bioavailability Enhancement of Coenzyme Q10: An Extensive Review of Patents.” Recent Pat Drug Deliv Formul 4 (2010): 245–257.
Benz, Chris, Tillis T, Tattelman E and Cadman E, et al. “Optimal Schedule of Methotrexate and 5-fluorouracil in Human Breast Cancer.” Cancer Res 42 (1982): 2081–2086.
Bentinger, Magnus, Brismar K and Dallner G. “The Antioxidant Role of Coenzyme Q.” Mitochondrion 7 (2007): 41-50.
Bentinger, Magnus, Tekle M and Dallner G. “Coenzyme QBiosynthesis and Functions.” Biochem Biophys Res Commun 396 (2010): 74–79.
Bertino JR, Mini E and Fernandes DJ. “Sequential Methotrexate and 5-fluorouracil: Mechanisms of Synergy.” Semin Oncol 10 (1983): 2–5.
Bhagavan, Hemmi N and Chopra RK. “Coenzyme Q10: Absorption, Tissue Uptake, Metabolism and Pharmacokinetics.” Free Radic Res 40 (2006): 445–453.
Bjelakovic, Goran, Nikolova D, Gluud LL and Simonetti RG, et al. “Mortality in Randomized Trials of Antioxidant Supplements for Primary And Secondary Prevention: Systematic Review and Meta-Analysis.” J Assoc Am Med Coll 297 (2007): 842–857.
Block, Keith I, Koch AC, Mead MN and Tothy PK, et al. “Impact of Antioxidant Supplementation on Chemotherapeutic Toxicity: a Systematic Review of The Evidence from Randomized Controlled Trials.” Int J Cancer 123 (2008): 1227–1239.
Bratosin D. “Cellular and Molecular Mechanisms of Senescent by Erythrocyte Phagocytosis Macrophages.” A review. Biochimie 80 (1998): 173–195.
de Pauw, Aurelia. “Mitochondrial Dysfunction In Adipocyte Dierentiation and Systemic Metabolic Alterations.” Am J Pathol 175 (2009): 927-912.
Kumar, Adarsh, Kaur H, Devi P and Mohan V, et al. “Role of Coenzyme Q10 (CoQ10) In Cardiac Disease, Hypertension and Meniere-Like Syndrome.” Pharmacol Therapeut 124 (2009): 259-259.
Mellors AL. Tappel. “The Inhibition of Mitochondrial Peroxidation by Ubiquinone and Ubiquinol.” J Biol Chem 241 (1966): 4353–4356.